Related Experiment Video

Updated: Aug 9, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

p27kip1 overexpression promotes paclitaxel-induced apoptosis in pRb-defective SaOs-2 cells

Chiara Gabellini1, Bruna Pucci, Paola Valdivieso

  • 1Experimental Chemotherapy Laboratory, Regina Elena Cancer Institute, Rome, Italy. gabellini@ifo.it

Journal of Cellular Biochemistry
|April 7, 2006
PubMed

Insights

Overexpressing p27kip1 in pRb-defective cancer cells enhances their susceptibility to paclitaxel-induced apoptosis. This suggests p27kip1 and proteasome inhibitors may be valuable therapeutic tools for these cancers.

Area of Science:

  • Molecular Biology
  • Cancer Cell Biology
  • Drug Discovery

Background:

  • p27kip1 is a cyclin-dependent kinase (CDK) inhibitor crucial for cell cycle regulation, often collaborating with pRb.
  • Paclitaxel is a chemotherapy agent that induces apoptosis.
  • pRb-defective cancers represent a significant therapeutic challenge.

Purpose of the Study:

  • To investigate the role of p27kip1 in paclitaxel-induced apoptosis in pRb-defective SaOs-2 cells.
  • To determine if p27kip1 overexpression enhances sensitivity to paclitaxel.
  • To explore the therapeutic potential of p27kip1 in pRb-defective cancers.

Main Methods:

  • SaOs-2 cells (pRb-defective) were treated with paclitaxel.
  • Ubiquitin-proteasome activity and caspase inhibition were assessed.
  • p27kip1 gene was overexpressed in SaOs-2 cells using plasmid transfection.
  • Apoptosis was quantified using Annexin V staining.

Main Results:

  • Paclitaxel treatment increased p27kip1 expression in SaOs-2 cells, linked to decreased ubiquitin-proteasome activity and apoptosis.
  • Caspase inhibition blocked the paclitaxel-induced increase in p27kip1.
  • SaOs-2 cells overexpressing p27kip1 showed significantly higher susceptibility (41.8% Annexin V-positive) to paclitaxel-induced apoptosis compared to controls (30.6%).

Conclusions:

  • p27kip1 overexpression increases the sensitivity of pRb-defective SaOs-2 cells to paclitaxel-induced apoptosis.
  • p27kip1 and proteasome inhibitors show promise as therapeutic agents for pRb-defective cancers.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...